Advanced Practice Midwife in Hampton, VA Accepting Medicare

9 Advanced Practice Midwife nurses found. Showing 1 - 9

Abbey Pachter, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 4000 W Mercury Blvd, Hampton, VA 23666 Phone: 757-826-2198    Fax: 757-825-9165

Lisa Pearl White, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 4000 Coliseum Dr Ste 280, Hampton, VA 23666 Phone: 757-827-2455    Fax: 757-452-5773

Ms. Traydacia Kiara Pendleton, CNM, MSN Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 4000 Coliseum Dr Ste 280, Hampton, VA 23666 Phone: 757-827-2455

Frances Harris, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 4000 Coliseum Dr Ste 280, Hampton, VA 23666 Phone: 757-827-2455    Fax: 757-452-5773

Jennifer Hatfield Farris, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2240 Coliseum Dr, Suite B, Hampton, VA 23666 Phone: 757-838-7277

Jamie Danielle Guertin, C.N.M. Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 77 Nealy Ave, Hampton, VA 23665 Phone: 757-225-7630

Victoria Rebecca Buchanan, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 4000 Coliseum Dr Ste 280, Hampton, VA 23666 Phone: 757-827-2455    Fax: 757-452-5773

Catherine Jones, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 77 Nealy Ave, Hampton, VA 23665 Phone: 757-225-7630    Fax: 757-223-9168

Kathleen Raney, NMW Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 910 W Mercury Blvd, Hampton, VA 23666 Phone: 757-826-2198    Fax: 757-825-9165

News Archive

New perspectives on biopharmaceutical value-based contracting

Value in Health, the official journal of ISPOR- the professional society for health economics and outcomes research, announced today the publication of a series of articles providing perspectives on biopharmaceutical value-based contracting and what the future may hold for risk-sharing arrangements.

Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint

Genentech, Inc. and Biogen Idec has announced that a Phase III study of Rituxan (rituximab) plus mycophenolate mofetil (MMF) and corticosteroids in patients with lupus nephritis did not meet its primary endpoint of significantly reducing disease activity at 52 weeks.

Pseudogenes may play key role in the discovery of new biomarkers

Dysfunctional, unloved and seemingly of little use, these poor-cousin relatives of genes have lost their protein-coding abilities. They contain material not essential for an organism's survival and are the "last stop" for removal of genomic waste.

Merge Healthcare to sell up to 9,034,033 shares of common stock to institutional investors

Merge Healthcare announced today that it is offering to sell up to 9,034,033 shares of common stock in a registered direct offering to select institutional investors at a purchase price of $3.00 per share. Merge expects to enter into definitive agreements with respect to this offering later today.

AGA introduces patient education initiative to help provide efficient care

The American Gastroenterological Association recognizes that physicians' time with patients is shrinking at the same time that patients want to share decision making with their providers

Read more Medical News

› Verified 5 days ago